CN113462611B - Nicotine-degrading Arthrobacter ureafaciens and application thereof - Google Patents
Nicotine-degrading Arthrobacter ureafaciens and application thereof Download PDFInfo
- Publication number
- CN113462611B CN113462611B CN202110873629.7A CN202110873629A CN113462611B CN 113462611 B CN113462611 B CN 113462611B CN 202110873629 A CN202110873629 A CN 202110873629A CN 113462611 B CN113462611 B CN 113462611B
- Authority
- CN
- China
- Prior art keywords
- nicotine
- czy1
- liquid
- strain
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001524178 Paenarthrobacter ureafaciens Species 0.000 title claims description 12
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims abstract description 72
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims abstract description 70
- 229960002715 nicotine Drugs 0.000 claims abstract description 70
- 241000208125 Nicotiana Species 0.000 claims abstract description 17
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 239000002699 waste material Substances 0.000 claims abstract description 12
- 230000015556 catabolic process Effects 0.000 claims abstract description 11
- 238000006731 degradation reaction Methods 0.000 claims abstract description 11
- 239000012880 LB liquid culture medium Substances 0.000 claims abstract description 9
- 238000012258 culturing Methods 0.000 claims abstract description 9
- 238000005070 sampling Methods 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 230000000593 degrading effect Effects 0.000 claims abstract description 7
- 230000004913 activation Effects 0.000 claims abstract description 6
- 239000001963 growth medium Substances 0.000 claims abstract description 6
- 238000012546 transfer Methods 0.000 claims abstract description 6
- 238000009630 liquid culture Methods 0.000 claims abstract description 5
- 238000004321 preservation Methods 0.000 claims abstract description 4
- 238000005406 washing Methods 0.000 claims abstract description 4
- 241000186063 Arthrobacter Species 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims abstract description 3
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 230000003213 activating effect Effects 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract description 11
- 239000004202 carbamide Substances 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 9
- 238000011081 inoculation Methods 0.000 abstract description 6
- 239000000725 suspension Substances 0.000 abstract description 6
- 239000000284 extract Substances 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000002054 inoculum Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000008223 sterile water Substances 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 238000010170 biological method Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000000779 smoke Substances 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 102000034337 acetylcholine receptors Human genes 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000002920 hazardous waste Substances 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000010841 municipal wastewater Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
- C02F2101/38—Organic compounds containing nitrogen
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Hydrology & Water Resources (AREA)
- Engineering & Computer Science (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses urea-producing arthrobacterium for degrading nicotine and application thereof, wherein the urea-producing arthrobacterium is urea-producing arthrobacterium CZY1 with a preservation number of CCTCC NO: M2021466, and the obtained strain CZY1 can be directly used for degrading nicotine in waste tobacco liquid extract in a reconstituted tobacco production process, and comprises activation, transfer culture and inoculation degradation, and the strain CZY1 is activated in an LB liquid culture medium; transfer culture: transferring the activated strain into a new LB liquid culture medium, culturing to a logarithmic phase, centrifugally stirring, washing and then re-suspending; transferring the heavy suspension bacteria liquid into BSM liquid culture medium containing a certain amount of nicotine, culturing under the conditions of a certain temperature, a certain pH and an inoculation amount, sampling and determining nicotine concentration and OD600。The method is simple to operate, and the obtained urea-producing arthrobacter CZY1 has high tolerance and high degradability to nicotine.
Description
Technical Field
The invention belongs to the technical field of microbial engineering, and particularly relates to urea-producing arthrobacterium capable of degrading nicotine and application thereof.
Background
As a special agricultural product, the tobacco has high domestic yield and generates a great amount of waste. The waste tobacco liquid extracting solution (TWE) in the reconstituted tobacco production process is liquid homogenate obtained by crushing tobacco wastes (tobacco stems, tobacco powder and partial low-grade tobacco leaves), performing solid-liquid separation after water extraction and performing film concentration, wherein the TWE is complex in physicochemical components and contains high-concentration nicotine, and degradation treatment of harmful substances such as nicotine is required before discharge, so that the ecological environment is prevented from being damaged.
Nicotine (Nicotine), also known as Nicotine, is an alkaloid present in plants of the solanaceae family (solanum genus) and is also one of the important constituents of tobacco. Nicotine, as an alkaloid, accounts for 95% of the total tobacco alkaloid and is a major factor responsible for cigarette addiction. As a highly toxic N-heterocyclic compound, nicotine can cross biological membranes and the blood brain barrier, interact with acetylcholine receptors, and cause various adverse reactions and even death. The United States Environmental Protection Agency (USEPA) has specified tobacco production waste streams with nicotine contents in excess of 500 mg/kg as "toxic release list" (TRI) chemicals (Dorgan, c.a. Statistical accepted of the environment, 3rd ed), and the european union has also established regulations that when nicotine contents are above 0.05% (w/w), they are classified as hazardous waste and must not be discharged directly to the environment without treatment, and the nicotine waste streams need to be treated separately and not allowed to be treated with other municipal waste or wastewater.
At present, physical, chemical and biological methods are mainly used in industry to treat nicotine in various wastes. Wherein the physical method mainly comprises an adsorption method and an extraction method, but the physical method does not substantially change the structure of the nicotine; the chemical methods have many kinds, but the basic principles are the same, namely, a strong oxidant is utilized to destroy the properties of functional groups or chemical bonds of nicotine so as to degrade the nicotine, however, the properties of the nicotine are stable, the boiling point is 274 ℃ and the melting point is-79 ℃, so that the chemical methods have the defects of high energy consumption, low efficiency, a large number of byproducts, secondary pollution easily caused by improper operation and the like, and further, the chemical methods are accompanied by high temperature and high heat, even open fire, and certain potential safety hazards exist in the production process. Under the condition, a green, environment-friendly and sustainable biological method is applied. The biological method utilizes some microorganisms which can take nicotine as a carbon and nitrogen source to degrade the nicotine, and has the advantages of low cost, easy culture, safety, environmental protection and the like.
At present, domestic reports on microorganisms with high nicotine tolerance are few, and related researches are not deeply developed.
Disclosure of Invention
The invention aims to provide urea arthrobacterium for degrading nicotine and application thereof, and urea arthrobacterium (A), (B) and (C)Paenarthrobacter ureafaciens) CZY1 shows better nicotine tolerance with some nicotine degradation ability.
Arthrobacter ureafaciens for degrading nicotinePaenarthrobacter ureafaciens) CZY1, depository: china center for type culture Collection; address: the institute of Life sciences of Wuhan university in Lojia mountain in Wuchang district, Wuhan, Hubei province; preservation day: 2021, 4 months and 27 days; the preservation number is CCTCC NO: M2021466.
Application of urea-producing arthrobacter CZY1 in nicotine degradation by waste tobacco liquid water extraction in a reconstituted tobacco production process.
Further, the applications include activation, transfer culture and inoculation degradation, and specifically include:
1) and (3) activation: activating the strain CZY1 in LB liquid culture medium;
2) transfer culture: transferring the activated strain into a new LB liquid culture medium, culturing to a logarithmic phase, centrifugally stirring, washing and then re-suspending;
3) transferring the re-suspended bacterial liquid into BSM liquid culture medium containing a certain amount of nicotine, culturing under the conditions of a certain temperature, a certain pH and an inoculation amount, sampling and measuring nicotine concentration and OD600。
Further, the temperature is 30-40 ℃, the PH is 5-8, the initial nicotine concentration is 2-14 g/L, and the inoculation amount is 1-6% (vol/vol).
The invention has the beneficial effects that: the screened Arthrobacter ureafaciens CZY1 has high tolerance and can effectively degrade nicotine.
Drawings
FIG. 1 is a perspective electron micrograph of strain CZY 1;
FIG. 2 is a phylogenetic evolutionary tree of CZY 1;
FIG. 3 shows the growth of the strain under nicotine conditions at different temperature conditions;
FIG. 4 shows the growth of strains under nicotine conditions at different pH values;
FIG. 5 shows the growth of the strains under nicotine conditions at different initial nicotine concentrations;
FIG. 6 shows the growth of strains under different inoculum size conditions in a nicotine environment;
FIG. 7 is a growth curve and a degradation curve of the strain in a medium.
Detailed Description
The invention is further illustrated by the following examples and figures of the specification.
Sample source: arthrobacter ureafaciens (Paenarthrobacter ureafaciens) CZY1 was isolated from TWE samples from hangzhou li group environmental protection paper industries ltd.
Example 1
Screening to obtain urea-producing arthrobacterium (II)Paenarthrobacter ureafaciens)CZY1:
1) Collecting a waste smoke liquid water extract sample:
a sample of the aqueous extract of waste tobacco smoke containing high concentration of nicotine was collected from Hangzhou Liqun environmental protection paper industries, Ltd, sealed with a sterilized culture bottle, and stored at 4 ℃.
2) Screening of high-tolerance nicotine-degrading strains:
for the primary screening of the high-tolerance nicotine-degrading bacterial strain, 25 mL of waste smoke liquid water extract is diluted into 100 mL by using sterile water, centrifuged at 3000 rpm for 3 min at normal temperature, supernatant is centrifuged at 5000 rpm for 2 min at normal temperature, supernatant is discarded, 5 mL of sterile water is used for resuspension and precipitation, centrifuged at 5000 rpm for 2 min at normal temperature, and the steps are repeated twice to wash out residual impurities. The precipitate was resuspended in 5 mL of sterile water to obtain crude cells. The crude cells were inoculated into 100 mL of Basic inorganic salt (BSM) liquid medium containing 8 g/L nicotine, and cultured at 30 ℃ and 180 rpm for 4 days. After the culture medium is turbid, a small amount of bacterial liquid dipped by an inoculating loop is streaked and separated on a BSM solid plate with the same concentration, and the culture is carried out in an inverted mode at the temperature of 30 ℃. After the single colony grows out, the single colony is streaked on a BSM solid plate with the same concentration again, inverted culture is carried out at 30 ℃ until a purified single colony is obtained, the pure single colony is inoculated into 100 mL of BSM liquid culture medium containing 8 g/L nicotine, and culture is carried out at 30 ℃ and 180 rpm for 4 days for re-screening verification.
Example 2
Separating strain morphology, physiological and biochemical identification:
the characteristics of the bacterial strains were further characterized using microbiological experiments (second edition, zhao bin, forest meeting, joshao kingdom) with the colony shape being circular, yellow, convex, smooth in surface, opaque in edges, purple in gram staining results, indicating positive, the result photographed by electron microscopy is shown in fig. 1, CZY1 being rod-shaped, having no spores, and having no flagella. The genus of the strain is determined according to 16S rRNA, the strain is determined according to Bergey' S handbook of bacteria, the strain is inoculated into LB liquid culture medium for overnight activation, and Ezup column type bacterial genome DNA extraction kit is used for extracting (biological engineering, Shanghai, China) total genome DNA according to the instruction. 16S rRNA was amplified using the universal primer, forward primer 27F (5'-AGAGTTTGATCCTGGCTCAG-3') and reverse primer 1492R (5'-GGTTACCTTGTTACGACTT-3'), and bacterial 16S rRNA sequences were amplified using the high fidelity polymerase 2 × Phanta Master Mix (Takara) in the following PCR reaction: 1 μ L of genomic DNA; 2 × Phanta Master Mix 25 μ L; primer F (10 μm) 2 μ L; primer R (10 μm) 2 μ L; ddH2O was supplemented to 50. mu.L. The PCR reaction procedure was as follows: initial temperature 95 ℃ for 3 minutes, 95 ℃ denaturation for 15 seconds, 60 ℃ annealing for 15 seconds, 72 ℃ extension for 15 seconds, cycle number 30, 72 ℃ final extension for 5 minutes, final hold at 16 ℃, PCR reaction fluid exchange by beijing optimak for sequencing, sequence alignment by NCBI with BLAST database, MEGA-X construction phylogenetic tree, ClusterW and adjacency method.
The results of the biochemical tests are shown in table 1:
TABLE 1 physiological and biochemical experimental results of strain CZY1
Detecting items | CZY1 |
Color of colony | Light yellow |
Gram stain | + |
Optimum pH | 7.0 |
|
30 |
Catalase Activity | + |
Methyl Red reaction | - |
Urease activity | + |
Amylase Activity | - |
Indole formation | - |
Acid production by glucose fermentation | - |
Fructose fermentation acid production | - |
Nitrate reduction reaction | + |
Hydrolysis reaction of gelatin | - |
16s rRNA sequencing results: 16S rRNA was amplified by using the universal primer, forward primer 27F (5'-AGAGTTTGATCCTGGCTCAG-3') and reverse primer 1492R (5'-GGTTACCTTGTTACGACTT-3'). The sequencing result of the PCR reaction solution is shown as SEQ ID NO. 1.
The specific result of the evolutionary tree is shown in FIG. 2, and the result shows that the strain CZY1 belongs to Arthrobacter ureafaciens.
Example 3
Optimum growth temperature experiment of isolated strains in nicotine environment:
activating the strain of example 1 in LB liquid culture medium overnight, transferring into new LB liquid culture medium, culturing at 30 deg.C and 180 rpm to logarithmic phase, centrifuging part of the strain at 5000 rpm for 2 min, washing with sterile water for 2 times, resuspending with appropriate amount of sterile water, transferring the resuspended strain into BSM liquid culture medium containing 2g/L nicotine under conditions of initial pH7.0, initial nicotine concentration 2g/L and inoculum size 2% (vol/vol), culturing at 180 rpm at different temperatures (30 deg.C, 35 deg.C, 37 deg.C and 40 deg.C) for 96 h, sampling, and determining OD600The optimum temperature was determined by setting 3 replicates for each group, and the result is shown in FIG. 3, where the optimum temperature was 30 ℃.
Example 4
Optimum growth PH conditions of the isolated strain in nicotine environment:
using the resuspended suspension of example 3, the suspension was incubated at 30 ℃ with an initial nicotine concentration of 2g/L and an inoculum size of 2% (vol/vol) at 180 rpm at different pH's (3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0) for 96 h, and the OD was determined by sampling600The optimum pH was determined by setting 3 replicates for each group and was 7.0 as shown in FIG. 4.
Example 5
Optimum initial nicotine concentration conditions of the isolated strain in nicotine environment:
the resuspended suspension of example 3 was used at a temperature of 30 ℃ and pH7.0 with an inoculum size of 2% (vol/vol) at different initial nicotine concentrations (2, 4, 6, 8,10. 12, 14, 16 g/L) at 180 rpm for 96 h, sampling and determining the OD600Each group was set to 3 replicates and the optimum initial nicotine concentration was determined, as can be seen from figure 5, the optimum initial nicotine concentration was 2 g/L.
Example 6
Optimum inoculum size of the isolated strain in nicotine environment:
using the resuspended suspension of example 3, the suspension was incubated at 30 ℃ and pH7.0 for 96 h at an initial nicotine concentration of 2g/L at 180 rpm with different inoculum sizes (2%, 3%, 4%, 5%, 6%, vol/vol), and the OD was determined by sampling600In this case, 3 replicates were set for each group, and the optimum inoculum size was determined, as shown in FIG. 6, which was 2% (vol/vol).
From the experiments of examples 3 to 6, the optimum growth conditions for CZY1 are: the temperature is 30 ℃, the pH is 7.0, the inoculation amount is 2 percent, the initial nicotine concentration is 2g/L, and the experimental result of the initial nicotine concentration shows that the maximum nicotine tolerance of CZY1 is 14 g/L.
Example 7
Strains (OD) which have been activated in LB liquid medium600=0.6 ± 0.05) into BSM liquid medium containing 2g/L nicotine, culturing at 180 rpm under optimum conditions, sampling every 8h, detecting nicotine residue concentration by High Performance Liquid Chromatography (HPLC) and drawing degradation curve, and sampling every 8h to detect OD600And a growth curve is plotted. The specific operation is as follows:
(1) drawing of degradation curves
Preparation of nicotine standard solution and preparation of standard curve: measuring a certain amount of nicotine stock solution, diluting with Up water to obtain standard solutions of 0.25 g/L, 0.50 g/L, 0.75 g/L and 1.00 g/L, respectively, measuring peak areas of the nicotine standard solutions by HPLC, wherein each concentration is parallel to three, the nicotine concentration is used as abscissa, and the corresponding peak area is used as ordinate to draw a standard curve. The HPLC method is as follows: the sample size was 10. mu.L, and the mobile phase was 0.01M KH, as determined by Agilent 1260 HPLC2PO4(prepared with Up water, pH adjusted to 3.0): methanol = 90: 10,the flow rate was 1.0 mL/min, the column was an Agilent SB-C18 column (4.6 mm. times.150 mm), the column temperature was room temperature, and the detection wavelength was 254 nm using a Diode Array (DAD) detector.
Detecting the concentration of the residual nicotine in the sample: 2mL of the bacterial solution is taken every 8 hours (including 0 hour), centrifuged at 12000 rpm for 10 min at normal temperature, and a proper amount of supernatant is sucked by a disposable sampler, filtered through a 0.22 mu m filter membrane and put into a liquid bottle. The peak area of the sample is obtained by the method in the step I, the concentration of the residual nicotine is calculated by a nicotine standard curve, and a nicotine degradation curve is drawn according to the concentration.
(2) Drawing of growth curves
2mL of the bacterial solution was taken every 8 hours (including 0 hour), centrifuged at 12000 rpm at room temperature for 10 min, and the supernatant was discarded. Resuspend the cells in the same volume (2 mL) of sterile water and measure OD at 600 nm by UV spectrophotometer600And drawing a growth curve according to the growth curve.
As shown in FIG. 7, after 104h of culture, CZY1 could completely degrade 2g/L nicotine, while CZY1 could grow to OD600≈3.0。
Sequence listing
<110> Zhejiang industrial university
<120> urea-producing arthrobacterium capable of degrading nicotine and application thereof
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1349
<212> DNA
<213> Arthrobacter ureafaciens producing urea (Paenarthrobacter ureafaciens)
<400> 1
cggcttcggg tgttacaact ttcgtgactt gacgggcggt gtgtacaagg cccgggaacg 60
tattcaccgc agcgttgctg atctgcgatt actagcgact ccgacttcat ggggtcgagt 120
tgcagacccc aatccgaact gagaccggct ttttgggatt agctccacct cacagtatcg 180
caaccctttg taccggccat tgtagcatgc gtgaagccca agacataagg ggcatgatga 240
tttgacgtcg tccccacctt cctccgagtt gaccccggca gtctcctatg agtccccggc 300
cgaaccgctg gcaacataga acgagggttg cgctcgttgc gggacttaac ccaacatctc 360
acgacacgag ctgacgacaa ccatgcacca cctgtaaacc ggccgcaagc ggggcacctg 420
tttccaggtc tttccggtcc atgtcaagcc ttggtaaggt tcttcgcgtt gcatcgaatt 480
aatccgcatg ctccgccgct tgtgcgggcc cccgtcaatt cctttgagtt ttagccttgc 540
ggccgtactc cccaggcggg gcacttaatg cgttagctac ggcgcggaaa acgtggaatg 600
tcccccacac ctagtgccca acgtttacgg catggactac cagggtatct aatcctgttc 660
gctccccatg ctttcgctcc tcagcgtcag ttacagccca gagacctgcc ttcgccatcg 720
gtgttcctcc tgatatctgc gcatttcacc gctacaccag gaattccagt ctcccctact 780
gcactctagt ctgcccgtac ccactgcaga accggagttg agccccggtc tttcacagca 840
gacgcgacaa accgcctacg agctctttac gcccaataat tccggataac gcttgcgccc 900
tacgtattac cgcggctgct ggcacgtagt tagccggcgc ttcttctgca agtaccgtca 960
cccccaaaga gggcttcttc cctactgaaa gaggtttaca acccgaaggc cgtcatccct 1020
cacgcggcgt cgctgcatca ggctttcgcc cattgtgcaa tattccccac tgctgcctcc 1080
cgtaggagtc tgggccgtgt ctcagtccca gtgtggccgg tcaccctctc aggccggcta 1140
cccgtcgtcg ccttggtagg ccattacccc accaacaagc tgataggccg cgagtccatc 1200
caaaaccaca aaaagctttc caccccccac catgcgatga ggagtcatat ccggtattag 1260
acccagtttc ccaggcttat cccagagtca agggcaggtt actcacgtgt tactcacccg 1320
ttcgccacta atccccggcg caagcaccg 1349
Claims (3)
1. Arthrobacter ureafaciens for degrading nicotinePaenarthrobacter ureafaciens) CZY1 with the preservation number of CCTCC NO: M2021466.
2. The use of Arthrobacter uregenes CZY1 as claimed in claim 1 in the degradation of nicotine by water extraction from waste tobacco liquid in reconstituted tobacco production process.
3. The use according to claim 2, wherein the use comprises activation, transfer culture and seed degradation, in particular comprising:
1) and (3) activation: activating the strain CZY1 in LB liquid culture medium;
2) transfer culture: transferring the activated strain into a new LB liquid culture medium, culturing to a logarithmic phase, centrifugally stirring, washing and then re-suspending;
3) transferring the resuspended bacterial liquid into a BSM liquid culture medium with the initial nicotine concentration of 2-14 g/L, culturing at the temperature of 30-40 ℃ and the pH of 5-8, and sampling to determine the nicotine concentration and OD600。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110873629.7A CN113462611B (en) | 2021-07-30 | 2021-07-30 | Nicotine-degrading Arthrobacter ureafaciens and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110873629.7A CN113462611B (en) | 2021-07-30 | 2021-07-30 | Nicotine-degrading Arthrobacter ureafaciens and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113462611A CN113462611A (en) | 2021-10-01 |
CN113462611B true CN113462611B (en) | 2022-06-17 |
Family
ID=77883462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110873629.7A Active CN113462611B (en) | 2021-07-30 | 2021-07-30 | Nicotine-degrading Arthrobacter ureafaciens and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113462611B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110713945B (en) * | 2019-09-05 | 2021-06-15 | 华南农业大学 | Bacteroides nicotinovorans and application thereof in disease control |
-
2021
- 2021-07-30 CN CN202110873629.7A patent/CN113462611B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN113462611A (en) | 2021-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107686820B (en) | Aerobic denitrifying bacteria and application thereof in water denitrification | |
US20240093142A1 (en) | Strain for degrading deoxynivalenol and use thereof | |
CN109706096B (en) | Cold-resistant brevibacterium strain with denitrification and efficient flocculation capacity and application thereof | |
CN114164133B (en) | Geobacillus thermodenitrification DC8 strain and application thereof | |
CN111621438B (en) | Wedner mannich bacillus LM-LZ separated from oxidation pond of pig farm and application thereof | |
CN111662839B (en) | Bacillus belgii for degrading tetracycline, magnetic immobilized microorganism composite material and application | |
CN113462611B (en) | Nicotine-degrading Arthrobacter ureafaciens and application thereof | |
CN115305226B (en) | Acinetobacter radioresistant ZJ-22 for degrading nicotine and producing hydrogen and application thereof | |
CN111378592B (en) | Bacillus licheniformis and method for treating malodorous organic wastewater by using same to purify water | |
CN107164280B (en) | Vomitoxin degrading bacterium and application thereof | |
CN106834165B (en) | Paracoccus capable of degrading penicillin, cell fraction and composition thereof | |
CN111621437B (en) | Otter escherichia coli LM-DK separated from oxidation pond of pig farm and application thereof | |
CN113373066B (en) | Humic acid degrading fungus HA-Z3 and application thereof | |
CN110004085B (en) | Brevibacterium LM-R separated from paint spraying wastewater bottom sediment and application thereof | |
CN109055254B (en) | Microbacterium with monomethylamine degradation capability and application thereof | |
JP4088690B2 (en) | New microorganisms and methods for removing arsenic by microorganisms | |
CN114907996A (en) | Kalipibeke Meyer yeast BJM3, application thereof in lincomycin degradation and microbial inoculum | |
CN114231448A (en) | Burkholderia contamination with indole degradation capability and application thereof | |
Kulichevskaya et al. | A novel filamentous planctomycete of the Isosphaera-Singulisphaera group isolated from a Sphagnum peat bog | |
CN111088197A (en) | Provevelis alcaligenes and application thereof in degrading tetracycline and producing auxin | |
CN114317380B (en) | Lactococcus lactis LXY-2 separated from soil of smelting plant and application thereof | |
CN114214260B (en) | Halomonas LYX-3 separated from soil of smelting plant and application thereof | |
CN114181863B (en) | Violet bacillus strain E1, preparation method thereof and application thereof in degradation of phthalate | |
CN103865853A (en) | Efficient degradation bacterium for quinclorac as well as use and use method thereof | |
CN113980869B (en) | Bacillus subtilis GDUTAN13 strain and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |